摘要
背景:轻度认知障碍更容易随着年龄的增长而发生,并且对于轻度认知障碍(MCI)和阿尔茨海默病(AD)的患者更为明显。反对的论点传统的识别认知下降的方法(即神经心理测试和临床判断)会导致认知功能障碍的假阳性诊断。 脑电图仪等工具脑电(EEG)提供了认知加工的额外指标,对与衰老、MCI和AD相关的电生理变化进行了索引。目的:回顾脑电的相关文献,以确定脑电是否听觉事件相关电位(ERPs)可区分健康衰老、MCI和AD. 方法:检索2005年1月至2017年4月期间发表的两个电子数据库(Medline和PyscInfo)。如果条款包括:1)与会者60年龄或以上;(2)健康的老年人或被诊断为MCI或AD的人;(3)至少有一个听觉诱发ERP成分。 结果:本研究共发现1532篇文章(去除重复后800篇),719篇通过标题/摘要审查排除,其余81篇中,30篇符合纳入标准。全钉IES比较了三个被选人群中至少两个群体的认知功能。我们的发现提示P 300和N 200成分可以区分健康认知老化,MCI和副词 结论:ERPs可能对MCI和AD所致的进行性认知改变敏感。P 300和N 200可能有助于鉴别那些有可能从MCI进展到AD的患者,并且可能是一种有价值的cl。邪恶的工具。
关键词: 阿尔茨海默病,事件相关电位,轻度认知障碍,P50,N 100,P 100,N 200,P 300。
Current Alzheimer Research
Title:Auditory Event-related Potentials in Mild Cognitive Impairment and Alzheimer’s Disease
Volume: 15 Issue: 8
关键词: 阿尔茨海默病,事件相关电位,轻度认知障碍,P50,N 100,P 100,N 200,P 300。
摘要: Background: Mild cognitive deficits are more likely to occur with increasing age, and become more pronounced for people diagnosed with mild cognitive impairment (MCI) and Alzheimer’s disease (AD). Conventional methods to identify cognitive declines (i.e., neuropsychological testing and clinical judgment) can lead to false positive diagnoses of cognitive impairment. Tools such as electroencephalography (EEG) offer additional measures of cognitive processing, indexing the electrophysiological changes associated with aging, MCI and AD.
Objective: We reviewed the literature on EEG to determine if auditory event-related potentials (ERPs) could distinguish between healthy aging, MCI, and AD.
Method: We searched two electronic databases (Medline and PyscInfo) for articles published between January 2005 and April 2017. Articles were considered for review if they included: i) participants 60 years of age or older; ii) healthy older adults or those diagnosed with MCI or AD; iii) at least one auditory elicited ERP component.
Results: Our search revealed 1532 articles (800 after removing duplicates); 719 were excluded through title/abstract review, and of the 81 remaining articles, 30 satisfied inclusion criteria. All studies compared cognitive function between at least two of the three selected populations. Our findings suggest that the P300 and N200 components may distinguish between healthy cognitive aging, MCI, and AD.
Conclusion: ERPs may be sensitive to progressive cognitive changes due to MCI and AD. The P300 and N200 may help identify patients who are likely to progress from MCI to AD, and could be a valuable clinical tool.
Export Options
About this article
Cite this article as:
Auditory Event-related Potentials in Mild Cognitive Impairment and Alzheimer’s Disease, Current Alzheimer Research 2018; 15 (8) . https://dx.doi.org/10.2174/1567205015666180123123209
DOI https://dx.doi.org/10.2174/1567205015666180123123209 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Inhibitors of AMPA and Kainate Receptors
Current Medicinal Chemistry Identification of Novel NaV1.7 Antagonists Using High Throughput Screening Platforms
Combinatorial Chemistry & High Throughput Screening Synthesis and Structure-Activity Relationships of 4,10-Dihydro-4-oxo-4HImidazo[ 1,2-a]Indeno[1,2-e]Pyrazine Derivatives: Highly Potent and Selective AMPA Receptor Antagonists with In Vivo Activity
Mini-Reviews in Medicinal Chemistry Tuberculosis Infections of the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Catatonia, Malignant Catatonia, and Neuroleptic Malignant Syndrome
Current Psychiatry Reviews Chemical Biology of mGlu4 Receptor Activation: Dogmas, Challenges, Strategies and Opportunities
Current Topics in Medicinal Chemistry Lamotrigine Pharmacokinetics During Anticonception and Pregnancy
Letters in Drug Design & Discovery Genome-Wide Expression Analysis of Valproate Action: A Systems Level Synthesis
Current Psychopharmacology Takotsubo Cardiomyopathy: What we have Learned in the Last 25 Years? (A Comparative Literature Review)
Current Cardiology Reviews The Large Conductance Calcium- and Voltage-activated Potassium Channel (BK) and Epilepsy
CNS & Neurological Disorders - Drug Targets 2, 5-Disubstituted Phthalimides: Design, Synthesis and Anticonvulsant Activity in scPTZ and MES Models
Current Computer-Aided Drug Design Involvement of Membrane Channels in Autoimmune Disorders
Current Pharmaceutical Design Inhibition of Monoamine Neurotransmitter Transporters and Central Nervous System Stimulation Induced by Synthetic Local Anesthetics and Cocaine: A Comparative Review-Update
Current Medicinal Chemistry - Central Nervous System Agents Classical Neurotransmitters and Neuropeptides Involved in Parkinson's Disease: Focus on Anti-Parkinsonian Drugs
Current Drug Therapy Synthesis and Evaluation of In Vivo Anticonvulsant Activity of 2,5- Disubstituted-1,3,4-Oxadiazole Derivatives
Letters in Drug Design & Discovery Editorial[Hot Topic:Membrane Channels as Therapeutic Targets (Executive Editor: Jean-Claude Herve)]
Current Pharmaceutical Design Targeting the Brain: Advances in Drug Delivery
Current Pharmaceutical Biotechnology Drug Treatment of Epilepsy: From Serendipitous Discovery to Evolutionary Mechanisms
Current Medicinal Chemistry Editorial (Thematic Issue: Targeting Transporters for CNS Drug Delivery)
Current Pharmaceutical Design α7 Nicotinic Acetylcholine Receptor Mediated Neuroprotection in Parkinson’s Disease
Current Drug Targets